AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients - Batchelor, T T; Sorensen, A G; di Tomaso, E (Cancer Cell, 2007)
, et al.